Literature DB >> 20587495

Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours.

J W Kim1, C-K Park, S-H Park, Y H Kim, J H Han, C-Y Kim, C-H Sohn, K-H Chang, H-W Jung.   

Abstract

OBJECTIVE: The radiological characteristics of World Health Organization grade III oligodendroglial tumours in relation to chromosome 1p and 19q deletions were analysed.
METHODS: 56 patients recently diagnosed with anaplastic oligodendroglioma (AO, n=49) or anaplastic oligoastrocytoma (AOA, n=7) were studied. Their preoperative magnetic resonance images were examined. Deletions of chromosome 1p and 19q were determined using the fluorescence in situ hybridisation method. Both 1p and 19q chromosomes had deletions (1p19q codeletion) in 39 patients (36 AO and 3 AOA).
RESULTS: Tumors associated with the 1p19q codeletion were predominantly located in the frontal lobe (p=0.044). The magnetic resonance image characteristics of indistinct tumour borders (p=0.005 on T1, p=0.036 on T2) and a heterogeneous intratumoural signal intensity (p=0.033 on T1, p=0.041 on T2) were significantly correlated with the 1p19q codeletion. Analysis of patient survival showed those with the 1p19q-co-deleted tumours survived significantly longer than those lacking the 1p19q codeletion (p=0.042). The presence of a heterogeneous signal intensity in T2-weighted images, a characteristic significantly related to the 1p19q codeletion, indicated a favourable prognosis for patients' survival (HR; 0.125, 95% CI, 0.016 to 0.963, p=0.046) based on multivariate analysis.
CONCLUSION: A relationship between radiological characteristics and molecular signatures in AO/AOAs was shown. It is believed that radiological characteristics have prognostic value as a surrogate marker for molecular characteristics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587495     DOI: 10.1136/jnnp.2009.178806

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Radiological features of supratentorial gliomas are associated with their genetic aberrations.

Authors:  Yuya Nishiyama; Hikaru Sasaki; Shinya Nagahisa; Kazihide Adachi; Takuro Hayashi; Koichiro Yoshida; Tsukasa Kawase; Natsuki Hattori; Kazuhiro Murayama; Masato Abe; Mitsuhiro Hasegawa; Yuichi Hirose
Journal:  Neurosurg Rev       Date:  2013-12-21       Impact factor: 3.042

2.  Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab.

Authors:  N Bahrami; D Piccioni; R Karunamuni; Y-H Chang; N White; R Delfanti; T M Seibert; J A Hattangadi-Gluth; A Dale; N Farid; C R McDonald
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

Review 3.  Genetics and imaging of oligodendroglial tumors.

Authors:  Jonathan R Ellenbogen; Carol Walker; Michael D Jenkinson
Journal:  CNS Oncol       Date:  2015-10-19

4.  Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review.

Authors:  Arian Lasocki; Mustafa Anjari; Suna Ӧrs Kokurcan; Stefanie C Thust
Journal:  Neuroradiology       Date:  2020-08-25       Impact factor: 2.804

5.  Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.

Authors:  J A Carrillo; A Lai; P L Nghiemphu; H J Kim; H S Phillips; S Kharbanda; P Moftakhar; S Lalaezari; W Yong; B M Ellingson; T F Cloughesy; W B Pope
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

6.  "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.

Authors:  Rajan Jain; Derek R Johnson; Sohil H Patel; Mauricio Castillo; Marion Smits; Martin J van den Bent; Andrew S Chi; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

7.  IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.

Authors:  Amélie Darlix; Jérémy Deverdun; Nicolas Menjot de Champfleur; Florence Castan; Sonia Zouaoui; Valérie Rigau; Michel Fabbro; Yordanka Yordanova; Emmanuelle Le Bars; Luc Bauchet; Catherine Gozé; Hugues Duffau
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

8.  Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.

Authors:  P P Batchala; T J E Muttikkal; J H Donahue; J T Patrie; D Schiff; C E Fadul; E K Mrachek; M-B Lopes; R Jain; S H Patel
Journal:  AJNR Am J Neuroradiol       Date:  2019-01-31       Impact factor: 3.825

9.  Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.

Authors:  Yinyan Wang; Kai Wang; Jiangfei Wang; Shaowu Li; Jun Ma; Jianping Dai; Tao Jiang
Journal:  Neuroradiology       Date:  2016-01-21       Impact factor: 2.804

10.  Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.

Authors:  Naeim Bahrami; Stephen J Hartman; Yu-Hsuan Chang; Rachel Delfanti; Nathan S White; Roshan Karunamuni; Tyler M Seibert; Anders M Dale; Jona A Hattangadi-Gluth; David Piccioni; Nikdokht Farid; Carrie R McDonald
Journal:  J Neurooncol       Date:  2018-06-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.